Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial

BACKGROUND AND AIMS The transjugular intrahepatic portosystemic shunt (TIPS) is a new therapeutic modality for variceal bleeding. In this study we compared the two year survival and rebleeding rates in cirrhotic patients treated by either variceal band ligation or TIPS for variceal bleeding. METHODS Eighty cirrhotic patients (Pugh score 7–12) with variceal bleeding were randomly allocated to TIPS (n=41) or ligation (n=39), 24 hours after control of bleeding. RESULTS Mean follow up was 581 days in the ligation group and 678 days in the TIPS group. The two year survival rate was 57% in the TIPS group and 56% in the ligation group (NS); the incidence of variceal rebleeding after two years was 18% in the TIPS group and 66% in the ligation group (p<0.001). Uncontrolled rebleeding occurred in 11 patients in the ligation group (eight were rescued by emergency TIPS) but in none of the TIPS group. The incidence of encephalopathy at two years was 47% in the TIPS group and 44% in the ligation group (NS). CONCLUSIONS TIPS did not increase the two year survival rate compared with variceal band ligation after variceal bleeding in cirrhotic patients with moderate or severe liver failure. It significantly reduced the incidence of variceal rebleeding without increasing the rate of encephalopathy.

[1]  A. Burroughs,et al.  Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta‐analysis , 1999, Hepatology.

[2]  M. Merli,et al.  Cost analysis for the prevention of variceal rebleeding: A comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of italian cirrhotic patients , 1999, Hepatology.

[3]  A. Gressner,et al.  Transformation-dependent calcium influx by voltage-operated calcium channels in stellate cells of rat liver. , 1999, Journal of hepatology.

[4]  A. Monescillo,et al.  Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage , 1999, Hepatology.

[5]  A. Monescillo,et al.  Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage , 1999 .

[6]  M. Merli,et al.  Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trial , 1998 .

[7]  B. M. Flynn,et al.  The effects of low dietary levels of polyunsaturates on alcohol‐induced liver disease in Rhesus monkeys , 1997, Hepatology.

[8]  W. Stremmel,et al.  Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. , 1997, Gastroenterology.

[9]  P. Hayes,et al.  A randomized trial comparing transjugular intrahepatic portosystemic stent‐shunt with variceal band ligation in the prevention of rebleeding from esophageal varices , 1997, Hepatology.

[10]  E. Olcott,et al.  Endoscopic Sclerotherapy Compared with Percutaneous Transjugular Intrahepatic Portosystemic Shunt after Initial Sclerotherapy in Patients with Acute Variceal Hemorrhage , 1997, Annals of Internal Medicine.

[11]  H. Blum,et al.  Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding , 1997, The Lancet.

[12]  T. Poynard,et al.  Beta‐adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta‐analysis , 1997, Hepatology.

[13]  J. Rank,et al.  Effect of transjugular intrahepatic portosystemic shunt on quality of life. , 1996, AJR. American journal of roentgenology.

[14]  X. Cussó,et al.  Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. , 1996, The New England journal of medicine.

[15]  M. Maynar,et al.  Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. , 1996, Gastroenterology.

[16]  D. Cook,et al.  Endoscopic Ligation Compared with Sclerotherapy for Treatment of Esophageal Variceal Bleeding , 1995, Annals of Internal Medicine.

[17]  G. D’Amico,et al.  The treatment of portal hypertension: A meta‐analytic review , 1995, Hepatology.

[18]  M. Lafortune,et al.  Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study. , 1995, AJR. American journal of roentgenology.

[19]  A Ochs,et al.  The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. , 1994, The New England journal of medicine.

[20]  J R Lake,et al.  Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. , 1993, Radiology.

[21]  E. Ring,et al.  Role of parallel transjugular intrahepatic portosystemic shunts in patients with persistent portal hypertension. , 1992, Radiology.

[22]  M. Bilodeau,et al.  Transjugular intrahepatic portacaval stent shunt as a rescue treatment for life-threatening variceal bleeding in a cirrhotic patient with severe liver failure. , 1992, The American journal of gastroenterology.

[23]  J. Palmaz,et al.  Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. , 1990, Radiology.

[24]  J. Villeneuve,et al.  Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a meta-analysis. , 1989, Gastroenterology.

[25]  J. Villeneuve,et al.  Prevention of variceal rebleeding by propranolol: Should it work? DOES IT WORK? , 1987, Hepatology.

[26]  J. Villeneuve,et al.  Clinical and statistical validity of conventional prognostic factors in predicting short‐term survival among cirrhotics , 1987, Hepatology.

[27]  D. Trunkey,et al.  Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. , 1984, The New England journal of medicine.

[28]  D. Graham,et al.  Variceal hemorrhage: a critical evaluation of survival analysis. , 1982, Gastroenterology.

[29]  D. Graham,et al.  The course of patients after variceal hemorrhage. , 1981, Gastroenterology.

[30]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[31]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[32]  P. Hayes,et al.  A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices , 1998 .

[33]  P. Cole,et al.  Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. , 1997, Annals of internal medicine.

[34]  R. Bell,et al.  Long-term survival after emergency portacaval shunting for bleeding varices in patients with alcoholic cirrhosis. , 1986, American journal of surgery.